🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several experts said the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has removed violative material and prohibited associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

Within moments of entering one group, a seller shared contact information, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Product Details and Costs

Inside these communities, posts display dark colored packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially significant medical dangers”.